Wilbur B. Bowne

5.7k citations
115 papers · 3.9k indexed · 1 hit paper · h-index 29

Wilbur B. Bowne

102 papers receiving 3.8k citations

Hit Papers

Merkel Cell Carcinoma: Prognosis and Treatment of Patient...5332005202620122019100200300400500

Peers

Wilbur B. Bowne
Comparison fields: 5 of 113
  • Oncology 2.0k
  • Immunology 858
  • Biomaterials 297
  • Rheumatology 332
  • Pulmonary and Respiratory Medicine 688
Replace Bita Esmaeli with:
Bita Esmaeli United States
Mauro Boiocchi Italy
Albert D. Donnenberg United States
Hidetoshi Okabe Japan
Cecilia Lässer Sweden
Peter Barth Germany
Fausto Sessa Italy
Sara Galimberti Italy
Tauseef Ahmed United States
Ferdinand Hofstaedter Germany
Wilbur B. Bowne relative to Bita Esmaeli United States Bita Esmaeli's profile →
Citations per field
00.5×1.5×
Bita Esmaeli · 1×
Citations per year

Countries citing papers authored by Wilbur B. Bowne

Since Specialization
Citations

This map shows the geographic impact of Wilbur B. Bowne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilbur B. Bowne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilbur B. Bowne more than expected).

Fields of papers citing papers by Wilbur B. Bowne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilbur B. Bowne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilbur B. Bowne. The network helps show where Wilbur B. Bowne may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wilbur B. Bowne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wilbur B. Bowne Line = papers co-authored together Wilbur B. Bowne links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20240
4 20240
5 20240
6 20240
7 20231
8 20231
9 201975
10 20181
11 20176
12 20153
13 20113
14
PNC-27 and PNC-28 anticancer peptides selectively kill cancer cells by pore formation dependent on the binding of these peptides to hdm2 in cancer cell membranes.
20081
15 200813
16 200730
17 2005131
18 200396
19
The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.
199931
20 1998185

About Wilbur B. Bowne

Wilbur B. Bowne is a scholar working on Oncology, Reproductive Medicine and Surgery, having authored 115 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (32 papers), Intraperitoneal and Appendiceal Malignancies (16 papers), Pancreatitis Pathology and Treatment (13 papers), Ovarian cancer diagnosis and treatment (10 papers), Immunotherapy and Immune Responses (10 papers), Appendicitis Diagnosis and Management (9 papers), Cancer-related Molecular Pathways (8 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Oncology (2.0k citations), Immunology (858 citations) and Biomaterials (297 citations). Wilbur B. Bowne has collaborated with scholars based in United States, New Zealand and Japan. Frequent co-authors include Murray F. Brennan, Jonathan J. Lewis, David P. Jaques, Peter J. Allen, Klaus J. Busam, Daniel G. Coit, William G. Hawkins, Alan N. Houghton, Jedd D. Wolchok and Roopa Srinivasan. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026